We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.85B
AUM Growth
-$497M
(-15%)
Cap. Flow
-$376M
Cap. Flow
% of AUM
-13.23%
Top 10 Holdings %
Top 10 Hldgs %
22.47%
Holding
2,268
New
669
Increased
298
Reduced
432
Closed
770
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$174M |
| 2 |
CTXS
Citrix Systems Inc
CTXS
|
+$134M |
| 3 |
Invitation Homes
INVH
|
+$46.4M |
| 4 |
Morgan Stanley
MS
|
+$44.3M |
| 5 |
Synopsys
SNPS
|
+$43.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$79.9M |
| 2 |
NXP Semiconductors
NXPI
|
+$52.5M |
| 3 |
Occidental Petroleum
OXY
|
+$45M |
| 4 |
Yum China
YUMC
|
+$40.8M |
| 5 |
iShares Biotechnology ETF
IBB
|
+$39M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 14.47% |
| 3 | Healthcare | 11.04% |
| 4 | Real Estate | 11% |
| 5 | Industrials | 9.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Pulse Biosciences
PLSE
$2.09B
| $85K | ﹤0.01% |
37,096
-27,587
| -43% | -$44.8K |
|
|
CONN
1402
DELISTED
Conn's Inc.
CONN
| $85K | ﹤0.01% |
12,000
-9,600
| -44% | -$91.3K |
|
1403
Praxis Precision Medicines
PRAX
$9.07B
| $83K | ﹤0.01% |
+2,432
| New | +$121K |
|
1404
Cheer Holding
CHR
$3.64M
| $82K | ﹤0.01% |
+37
| New | +$75K |
|
1405
Getty Images
GETY
$184M
| $80K | ﹤0.01% |
+11,715
| New | +$221K |
|
|
OYST
1406
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $80K | ﹤0.01% |
14,172
-20,580
| -59% | -$129K |
|
1407
Eos Energy Enterprises
EOSE
$1.23B
| $79K | ﹤0.01% |
47,532
-172,268
| -78% | -$376K |
|
1408
Immunic
IMUX
$182M
| $78K | ﹤0.01% |
2,473
-6,567
| -73% | -$275K |
|
|
QUOT
1409
DELISTED
Quotient Technology Inc
QUOT
| $77K | ﹤0.01% |
+33,168
| New | +$81.3K |
|
1410
Elicio Therapeutics
ELTX
$78.8M
| $73K | ﹤0.01% |
7,886
-1,047
| -12% | -$10.9K |
|
1411
UWM Holdings
UWMC
$621M
| $73K | ﹤0.01% |
24,793
-356,809
| -94% | -$1.31M |
|
|
ONCR
1412
DELISTED
Oncorus, Inc.
ONCR
| $73K | ﹤0.01% |
86,135
-12,465
| -13% | -$16K |
|
1413
Geron
GERN
$911M
| $72K | ﹤0.01% |
+30,889
| New | +$69.2K |
|
1414
LiveOne
LVO
$66M
| $71K | ﹤0.01% |
9,940
-20,010
| -67% | -$211K |
|
|
TECX
1415
Tectonic Therapeutic
TECX
$573M
| $71K | ﹤0.01% |
9,146
-2,441
| -21% | -$27.1K |
|
1416
Aveanna Healthcare
AVAH
$2.06B
| $70K | ﹤0.01% |
+46,677
| New | +$95.9K |
|
1417
Immunovant
IMVT
$8.09B
| $69K | ﹤0.01% |
12,400
-2,526
| -17% | -$12.3K |
|
1418
Acacia Research
ACTG
$450M
| $68K | ﹤0.01% |
16,790
-235,110
| -93% | -$1.09M |
|
|
HARP
1419
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $68K | ﹤0.01% |
7,005
-2,185
| -24% | -$40.8K |
|
1420
Sky Harbour Group
SKYH
$351M
| $67K | ﹤0.01% |
18,313
-65,941
| -78% | -$312K |
|
|
TRHC
1421
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $66K | ﹤0.01% |
13,715
-112,677
| -89% | -$483K |
|
1422
Ribbon Communications
RBBN
$354M
| $65K | ﹤0.01% |
+29,494
| New | +$93.4K |
|
1423
Butterfly Network
BFLY
$1.72B
| $64K | ﹤0.01% |
13,695
-396,161
| -97% | -$2.09M |
|
1424
Ceragon Networks
CRNT
$194M
| $64K | ﹤0.01% |
34,600
| – | – |
|
|
TBIO
1425
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
| $63K | ﹤0.01% |
2,096
-102
| -5% | -$3.59K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q3 2022 Portfolio in Review
As of Q3 2022, Ergoteles held 2,268 positions worth $2.85B, down 15% from $3.34B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ergoteles withdrew a net $376M in Q3 2022, closing 770 positions and reducing 432 holdings. Its most notable exit was Yum China, an estimated $40.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Ergoteles opened a new position in Morgan Stanley worth $41.5M.
- Ergoteles's largest Q3 2022 buy was Morgan Stanley: 525,381 shares worth $41.5M.
- Ergoteles added most to Duke Realty Corp. in Q3 2022, an estimated $174M increase.
- Ergoteles's biggest Q3 2022 reduction was State Street Technology Select Sector SPDR ETF, cutting an estimated $79.9M.
- Ergoteles fully exited Yum China in Q3 2022, selling an estimated $40.8M.
- Ergoteles's ten largest holdings make up 22% of its $2.85B portfolio in Q3 2022.
- Ergoteles opened 669 new positions and closed 770 in Q3 2022.
- Ergoteles's portfolio value fell 15% quarter-over-quarter to $2.85B.
Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.